Concepedia

Adam Albitar

AA

Statistics

Publications

3

Citations

381

H-Index

3

Active since

2016

Affiliations

NeoGenomics (United States)(Current)

National Cancer Institute

National Heart Lung and Blood Institute

Adam Albitar is an author at NeoGenomics (United States) specializing in oncology, chronic lymphocytic leukemia therapy, and molecular oncology.

Publications per year

2016–2017

3

Publications

3

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia

Inhye E. Ahn, Chingiz Underbayev, Adam Albitar et al. · Blood · 2017 · 342 citations · Full text

, , +14

Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors

Adam Albitar, Wanlong Ma, Ivan DeDios et al. · Oncotarget · 2017 · 29 citations · Full text

, , +14

Positive selection and high sensitivity test for MYD88 mutations using locked nucleic acid

Adam Albitar, W. Ma, Ivan DeDios et al. · International Journal of Laboratory Hematology · 2016 · 10 citations

, , +17

1–3 of 3